Literature DB >> 31326481

Preventive Management of Nonobstructive CAD After Coronary CT Angiography in the Emergency Department.

Michael C Honigberg1, Bradley S Lander2, Vinit Baliyan3, Maeve Jones-O'Connor2, Emma W Healy4, Jan-Erik Scholtz5, John T Nagurney6, Udo Hoffmann7, Brian B Ghoshhajra3, Pradeep Natarajan8.   

Abstract

OBJECTIVES: This study sought to assess medical management of patients found to have nonobstructive coronary artery disease (CAD) on coronary computed tomography angiography (CCTA) performed in the emergency department (ED).
BACKGROUND: Contemporary recognition and management of nonobstructive CAD discovered on CCTA performed in the ED is unknown.
METHODS: Patients undergoing CCTA in the authors' hospital's ED between November 2013 and March 2018 who also received primary care within the authors' health system were studied. All patients with nonobstructive CAD, defined as 1% to 49% maximum luminal stenosis on CCTA, were included, along with a control group without CAD in a 1 case:1 control fashion. Ten-year atherosclerotic cardiovascular disease (ASCVD) risk prior to CCTA was estimated using the Pooled Cohort Equations. Management changes were recorded until 6 months after CCTA. Multivariate logistic regression tested the association between CCTA result and follow-up statin prescription, adjusting for cardiovascular risk factors and baseline statin use.
RESULTS: The cohort included 510 patients with nonobstructive CAD and 510 controls. Prevalence of statin prescription increased from 38.8% to 56.1% among patients with nonobstructive CAD (p < 0.001) and 18.0% to 20.4% among controls (p = 0.01), representing a 7.1-fold relative difference (95% confidence interval [CI]: 4.4 to 23.0; p < 0.001) in multivariate analysis. However, 30.0% of patients with nonobstructive CAD and ≥20% 10-year ASCVD risk were not prescribed a statin at the end of follow-up. Cardiologist evaluation was independently associated with statin prescription after adjustment for ASCVD risk factors (odds ratio [OR] 4.4; 95% CI: 2.4 to 8.5; p < 0.001). A Coronary Artery Disease Reporting and Data System class 1 to 2 result was associated with lower low-density lipoprotein cholesterol by 12.1 mg/dl at mean 1.9-year follow-up (p < 0.001).
CONCLUSIONS: Incidental subclinical atherosclerosis on CCTA performed in the ED increases the likelihood of statin prescription, but opportunities to improve allocation of indicated preventive therapies remain.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT coronary angiography; atherosclerosis; prevention; statin

Mesh:

Substances:

Year:  2019        PMID: 31326481      PMCID: PMC6954346          DOI: 10.1016/j.jcmg.2019.04.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  36 in total

1.  The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial.

Authors:  James A Goldstein; Kavitha M Chinnaiyan; Aiden Abidov; Stephan Achenbach; Daniel S Berman; Sean W Hayes; Udo Hoffmann; John R Lesser; Issam A Mikati; Brian J O'Neil; Leslee J Shaw; Michael Y H Shen; Uma S Valeti; Gilbert L Raff
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.

Authors:  Joshua D Mitchell; Nicole Fergestrom; Brian F Gage; Robert Paisley; Patrick Moon; Eric Novak; Michael Cheezum; Leslee J Shaw; Todd C Villines
Journal:  J Am Coll Cardiol       Date:  2018-12-25       Impact factor: 24.094

3.  The 10-Year Prognostic Value of Zero and Minimal CAC.

Authors:  Parag H Joshi; Michael J Blaha; Matthew J Budoff; Michael D Miedema; Robyn L McClelland; Joao A C Lima; Arthur S Agatston; Ron Blankstein; Roger S Blumenthal; Khurram Nasir
Journal:  JACC Cardiovasc Imaging       Date:  2017-08

4.  Coronary Computed Tomography Angiography Versus Radionuclide Myocardial Perfusion Imaging in Patients With Chest Pain Admitted to Telemetry: A Randomized Trial.

Authors:  Jeffrey M Levsky; Daniel M Spevack; Mark I Travin; Mark A Menegus; Paul W Huang; Elana T Clark; Choo-Won Kim; Esther Hirschhorn; Katherine D Freeman; Jonathan N Tobin; Linda B Haramati
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

5.  Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.

Authors:  David E Newby; Philip D Adamson; Colin Berry; Nicholas A Boon; Marc R Dweck; Marcus Flather; John Forbes; Amanda Hunter; Stephanie Lewis; Scott MacLean; Nicholas L Mills; John Norrie; Giles Roditi; Anoop S V Shah; Adam D Timmis; Edwin J R van Beek; Michelle C Williams
Journal:  N Engl J Med       Date:  2018-08-25       Impact factor: 91.245

6.  Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Matthew J Budoff; Robyn L McClelland; Khurram Nasir; Philip Greenland; Richard A Kronmal; George T Kondos; Steven Shea; Joao A C Lima; Roger S Blumenthal
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

Review 7.  Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis.

Authors:  Andrew J Foy; Sanket S Dhruva; Brandon Peterson; John M Mandrola; Daniel J Morgan; Rita F Redberg
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

8.  Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.

Authors:  Amit Pursnani; Csilla Celeng; Christopher L Schlett; Thomas Mayrhofer; Pearl Zakroysky; Hang Lee; Maros Ferencik; Jerome L Fleg; Fabian Bamberg; Stephen D Wiviott; Quynh A Truong; James E Udelson; John T Nagurney; Udo Hoffmann
Journal:  Am J Cardiol       Date:  2015-11-18       Impact factor: 2.778

9.  Comparative effectiveness of coronary CT angiography vs stress cardiac imaging in patients following hospital admission for chest pain work-up: The Prospective First Evaluation in Chest Pain (PERFECT) Trial.

Authors:  Seth Uretsky; Edgar Argulian; Azhar Supariwala; Shiv K Agarwal; Georges El-Hayek; Patricia Chavez; Hira Awan; Ashadevi Jagarlamudi; Siva P Puppala; Randy Cohen; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2016-04-05       Impact factor: 5.952

10.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.

Authors:  John J McNeil; Rory Wolfe; Robyn L Woods; Andrew M Tonkin; Geoffrey A Donnan; Mark R Nelson; Christopher M Reid; Jessica E Lockery; Brenda Kirpach; Elsdon Storey; Raj C Shah; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Colin I Johnston; Joanne Ryan; Barbara Radziszewska; Michael Jelinek; Mobin Malik; Charles B Eaton; Donna Brauer; Geoff Cloud; Erica M Wood; Suzanne E Mahady; Suzanne Satterfield; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

View more
  5 in total

1.  Machine Learning CT FFR: The Evolving Role of On-Site Techniques.

Authors:  Abdul Rahman Ihdayhid; Sagit Ben Zekry
Journal:  Radiol Cardiothorac Imaging       Date:  2020-06-25

Review 2.  SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.

Authors:  Jagat Narula; Y Chandrashekhar; Amir Ahmadi; Suhny Abbara; Daniel S Berman; Ron Blankstein; Jonathon Leipsic; David Newby; Edward D Nicol; Koen Nieman; Leslee Shaw; Todd C Villines; Michelle Williams; Harvey S Hecht
Journal:  J Cardiovasc Comput Tomogr       Date:  2020-11-20

3.  IL-6-targeted ultrasmall superparamagnetic iron oxide nanoparticles for optimized MRI detection of atherosclerotic vulnerable plaques in rabbits.

Authors:  Huaqiang Mo; Chenxing Fu; Zhiye Wu; Peng Liu; Zhibo Wen; Qingqing Hong; Yanbin Cai; Gongxin Li
Journal:  RSC Adv       Date:  2020-04-17       Impact factor: 3.361

4.  Use of Preventive Medications in Patients With Nonobstructive Coronary Artery Disease: Analysis of the PROMISE Trial.

Authors:  Ricky D Turgeon; Tara Sedlak
Journal:  CJC Open       Date:  2020-10-05

5.  Prognostic implications of left ventricular mass-geometry in patients with no or nonobstructive coronary artery disease.

Authors:  You-Jung Choi; Jun-Bean Park; Chan Soon Park; Inchang Hwang; Yeonyee E Yoon; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim; Goo-Yeong Cho; Dae-Won Sohn
Journal:  BMC Cardiovasc Disord       Date:  2021-04-15       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.